Form 4: Phibro Animal Health Corp Director E. Thomas Corcoran Acquires 5,000 Shares

Director E. Thomas Corcoran of Phibro Animal Health Corp purchased 5,000 shares of Class A Common Stock at an average price of $20.02 on September 4, 2024.

Summary

• On September 4, 2024, E. Thomas Corcoran, a director of Phibro Animal Health Corp, acquired 5,000 shares of Class A Common Stock.
• The purchase was made at a weighted average price of $20.02 per share, with individual transactions ranging from $19.89 to $20.20.
• Following the transaction, Corcoran directly owns 25,000 shares of Phibro Animal Health Corp.
• A Power of Attorney was executed on September 6, 2024, granting Judith Weinstein and Henry Ko the authority to handle Section 16 reporting obligations on behalf of Corcoran.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's performance and future prospects within the animal health industry.

Comparison to Industry Standards

• Comparing Corcoran's transaction to similar insider transactions in comparable animal health companies like Zoetis or Elanco Animal Health could provide context on the significance of this purchase.
• Analyzing the size of the transaction relative to Corcoran's existing holdings and the company's market capitalization can offer further insights.
• Benchmarking the transaction against industry averages for insider buying activity can help determine if this is a typical or noteworthy event.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates